Broadwood opposes Alcon's STAAR Surgical acquisition bid

Go back to Broadwood opposes Alcon's STAAR Surgical acquisition bid

Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects

November 4, 2025 11:52 AM UTC

Reminds STAARs Board That It Does Not Need Alcons Permission to Remain Independent or Run a Proper Strategic Alternatives Process

NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on the investor presentation issued by Alcon Inc. (Alcon) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAARs outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN Proxy... More